Lectures and seminars Webinar on Current Clinical Status of Amyloid-targeting Therapy for Alzheimer’s Disease

Find out more about limitations as well as potential utility of amyloid-targeting approaches to slow the progression of Alzheimer’s Disease (AD). The amyloid-targeting drugs can change the course of AD in selected population at the early stages. At the same time, treatments have also been shown to have significant side effects. Even health economic aspects need to be considered.

The previous and current fellows from the Master´s Courses in Dementia Care for Physicians are also invited to the webinar to discuss how the clinics are prepared for future challenges in diagnosis and treatment of AD. A brief Information about the forthcoming course will also be given at the end of the webinar. 

The event is prepared in collaboration with (Swedish registry for cognitive/dementia disorders (SveDem).